Skip to Content
Merck
CN
  • Preparation and characterization of nano-hydroxyapatite nanomaterials for liver cancer cell treatment.

Preparation and characterization of nano-hydroxyapatite nanomaterials for liver cancer cell treatment.

Journal of nanoscience and nanotechnology (2013-06-13)
Sathiyamoorthy Ezhaveni, Rathinam Yuvakkumar, Mani Rajkumar, Nachiappan Meenakshi Sundaram, Venkatachalam Rajendran
ABSTRACT

Nano-hydroxyapatite was synthesized by means of the hydrothermal treatment. The effects of nano-hydroxyapatite material on the behaviour of G2 liver cancer cells were explored. About 50% of cell viability was lost in nHAp material treated cells at 200 degrees C @ 5 h, followed by -30% in nHAp treated cells at 100 degrees C @ 5 h. Compared with control, nHAp material treated cells at 200 degrees C @ 5 h showed 60% and nHAp material treated cells at 100 degrees C @ 5 h showed 15% morphological change. Moreover, 50% of cell death was observed at 24 h incubation with nHAp material treated at 200 degrees C @ 5 h cells and 56% cell death at 48 h incubation and hence alters and disturbs the growth of cancer cells. In contrast, the nHAp material treated at 100 degrees C @ 5 h protects the cells and could be used for liver cancer cell treatment.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydroxyapatite, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
Sigma-Aldrich
Hydroxyapatite, purum p.a., ≥90% (as Ca3(PO4)2, KT)